Online Training 2015 - How to Respond to an FDA Investigation: What happens when the FDA threatens to shut you? - By Compliance Global Inc
Date2015-10-13
Deadline2015-10-13
VenueOnline Webinar, USA - United States
KeywordsFDA Investigation; Fda regulation; Evenue loss
Topics/Call fo Papers
Overview:
FDA investigations can lead to observations requiring remediation, disruption of your business, loss of revenue and enforcement actions up to and including having your plant shutdown.
Come learn from someone who's "been there and done that" having gone through an intense FDA investigation with a global manufacturer of durable medical equipment that resulted in the imposition of a Consent Decree and plant shutdown.
Take-away will include practical tips on how to interact with the FDA and create sustainable corrective actions.
Why Should You Attend:
How would you respond to an FDA investigation? It could be a FDA 483 letter, a warning letter, or a Consent Decree, all of which will impact revenue loss & how you carry on your business while under investigation.
Drew Barnholtz has "been there, done that" when it comes to the FDA investigation and Consent Decree process. Learn first-hand of his experience and how his company survived the ordeal.
Areas Covered in this Webinar:
What a company should do if the FDA shows up unannounced
How a company should respond to 483 observations or a warning letter
The affect an FDA investigation can have on a company
The basic concepts that should be employed by everyone regulated by the FDA
How a company can prepare for situations like the this
Lesson learned
Learning Objectives:
Learn how a company can balance the need to prepare for a potential FDA investigation or enforcement action and still run a profitable business.
Who Will Benefit:
CEOs
CFOs
Quality Affairs Personnel
Regulatory Affairs Personnel
General Counsel/Legal Professionals
Manufacturing Professionals
Engineering Professionals
Distribution Professionals
Supply Chain Professionals
Level:
Beginner
For more detail please click on this below link:
https://complianceglobal.us/product/700204/
Email: referrals-AT-complianceglobal.us
Toll Free: +1-844-746-4244
Tel: +1-516-900-5515
FDA investigations can lead to observations requiring remediation, disruption of your business, loss of revenue and enforcement actions up to and including having your plant shutdown.
Come learn from someone who's "been there and done that" having gone through an intense FDA investigation with a global manufacturer of durable medical equipment that resulted in the imposition of a Consent Decree and plant shutdown.
Take-away will include practical tips on how to interact with the FDA and create sustainable corrective actions.
Why Should You Attend:
How would you respond to an FDA investigation? It could be a FDA 483 letter, a warning letter, or a Consent Decree, all of which will impact revenue loss & how you carry on your business while under investigation.
Drew Barnholtz has "been there, done that" when it comes to the FDA investigation and Consent Decree process. Learn first-hand of his experience and how his company survived the ordeal.
Areas Covered in this Webinar:
What a company should do if the FDA shows up unannounced
How a company should respond to 483 observations or a warning letter
The affect an FDA investigation can have on a company
The basic concepts that should be employed by everyone regulated by the FDA
How a company can prepare for situations like the this
Lesson learned
Learning Objectives:
Learn how a company can balance the need to prepare for a potential FDA investigation or enforcement action and still run a profitable business.
Who Will Benefit:
CEOs
CFOs
Quality Affairs Personnel
Regulatory Affairs Personnel
General Counsel/Legal Professionals
Manufacturing Professionals
Engineering Professionals
Distribution Professionals
Supply Chain Professionals
Level:
Beginner
For more detail please click on this below link:
https://complianceglobal.us/product/700204/
Email: referrals-AT-complianceglobal.us
Toll Free: +1-844-746-4244
Tel: +1-516-900-5515
Other CFPs
- Impact on Exporters of Foreign Assets Control, Anti-Boycott and Anti-Money Laundering Regulations - By Compliance Global Inc
- The 2nd Conference on Advances in Biochemistry and Molecular Biology (CABMB 2016)
- The 2nd Conference on Advances in Cell Biology (CACB 2016)
- 2016 3rd International Conference on Biomedical and Pharmaceutical Engineering (ICBPE 2016)
- 2016 2nd International Conference on Chemical Materials and Process (ICCMP 2016)
Last modified: 2015-09-04 20:20:58